StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ALMER.PA$4.56+8.53%
Fair $4.56+0.0%

ALMER.PA

Sapmer SA

Consumer Defensive / Packaged FoodsParis

$4.56

+0.36 (+8.53%)

Fairly Valued+0.0%Fair Value $4.56Fund rank 26/100 · Data gapFallback financials|
SA 15/F
F-Score: 4/9
Declining RevenueMargin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $1.1M · quality 37.3/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

15/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 3unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years Operating margin has declined for 3 consecutive years ROE is -74.1%, below the 5% threshold
Thesis & Journal · ALMER.PALocal privado en este navegador · Sapmer SA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$28M

P/E

N/A

•

EV/EBITDA

8.0x

↓

ROE

-74.1%

↓

Gross Margin

75.7%

↑

Debt/Equity

1.70

↑
52-Week Range$5
$4$8

TradingView lightweight chart

ALMER.PA price, volumen y niveles de valoración

Último $4.580Periodo -69.5%
Fair value: $4.560

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-16.8%

FCF CAGR

-63.6%

FCF margin

1.1%

FCF / Net income

-0.06x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $93.9M · net income $-18.3M · FCF $1.1M

2022-FY → 2025-FY

Gross margin

75.7%+3.6% pts

Operating margin

-22.6%-32.2% pts

Net margin

-19.4%-23.0% pts

FCF margin

1.1%-12.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$93.9M$93.9M$102.7M$141.5M$163.2M
Net Income$-18.3M$-18.3M$-876000.00$-30.8M$5.8M
EBITDA$8.1M$8.1M$7.2M$-17.8M$27.7M
EPS——-0.18-8.791.66
Gross Margin75.7%75.7%69.3%65.2%72.1%
Operating Margin-22.6%-22.6%0.8%2.7%9.7%
Net Margin-19.4%-19.4%-0.9%-21.7%3.6%
Balance Sheet
Debt/Equity1.701.701.212.101.74
Current Ratio1.211.21———
Cash Flow
Free Cash Flow$1.1M$1.1M$-6.8M$11.4M$21.8M
Returns
ROE-74.1%-74.1%-2.3%-131.3%10.8%
Valuation
P/E————7.71
EV/EBITDA7.987.9810.79—4.79
P/B1.131.130.971.490.84
Growth & Yield
Revenue Growth-8.6%-8.6%-27.4%-13.3%—
EPS Growth——98.0%-629.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -39.7%

Total return

-39.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.18 → n/d

Residual

-39.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-39.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.